Atlantic Union Bankshares’s GT Biopharma GTBP Stock Holding History

Atlantic Union Bankshares’s Portfolio GTBP Stock Details GTBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62K	Buy	+5,351	New	+$2.17K	﹤0.01%	1521

Other funds holding GTBP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

OWA

Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

4WM

49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return

Alongside Austin, Texas $525M AUM

Atlantic Union Bankshares's GTBP Position: Q2 2026 in Review

Atlantic Union Bankshares opened a new position in GT Biopharma (GTBP) in Q2 2026: 5,351 shares worth $2.62K. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings.

59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

Atlantic Union Bankshares held 5,351 shares of GT Biopharma worth $2.62K as of Q2 2026.
GT Biopharma was a new Atlantic Union Bankshares position in Q2 2026.
GT Biopharma made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1521 holding.
59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.